Research Article
Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents
Table 4
Outcomes at 30 days: bivalirudin versus heparin in patients with ESRD undergoing PCI.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Any of the following 30-day outcomes: mortality, MI, heart failure, stroke, or TVR; †no stroke events were reported in either group; ‡if there are fewer than 7 cases/events, the exact number is not disclosed per the Massachusetts Department of Public Health; ESRD, end-stage renal disease; PCI, percutaneous coronary intervention; UFH, unfractionated heparin; LMWH, low molecular weight heparin; MI, myocardial infarction; TVR, target vessel revascularization; NA, not available; BMS, bare-metal stent; DES, drug-eluting stent. |